Pharmacological studies with a nonpeptidic, delta-opioid (−)-(1R,5R,9R)-5,9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((−)-NIH 11082)

This publication has 37 references indexed in Scilit:

• A Comparison of the Antinociceptive and Adverse Effects of the μ‐Opioid Agonist Morphine and the δ‐Opioid Agonist SNC80
  Basic & Clinical Pharmacology & Toxicology, 2005
• Nociceptive Sensitivity and Opioid Antinociception and Antihyperalgesia in Freund’s Adjuvant-Induced Arthritic Male and Female Rats
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Different Structural States of the Proteolipid Membrane Are Produced by Ligand Binding to the Human δ-Opioid Receptor as Shown by Plasmon-Waveguide Resonance Spectroscopy
  Molecular Pharmacology, 2004
• Antihyperalgesic effects of δ opioid agonists in a rat model of chronic inflammation
  British Journal of Pharmacology, 2000
• Antipodal .alpha.-N-(Methyl through Decyl)-N-normetazocines (5,9.alpha.-Dimethyl-2'-hydroxy-6,7-benzomorphans): In vitro and In vivo Properties
  Journal of Medicinal Chemistry, 1994
• Cloning and pharmacological characterization of a rat μ opioid receptor
  Neuron, 1993
• Immunomodulation of human T cell responses with receptor selective enkephalins
  Immunology Letters, 1993
• Cloning of a Delta Opioid Receptor by Functional Expression
  Science, 1992
• Role of spacer and address components in peptidomimetic .delta.-opioid receptor antagonists related to naltrindole
  Journal of Medicinal Chemistry, 1991
• The Effects of Naloxone and Nalorphine during the Development of Morphine Dependence in Rhesus Monkeys
  Pharmacology, 1977